Strategic Partnerships Strategic partnerships with large medtech incumbents can accelerate scale by supplying specialized biomaterials for wound healing and hemostasis as an OEM or co development partner.

Market Expansion Leverage core capabilities in wound healing and hemostasis to target trauma surgical and orthopedic markets through licensing or joint development with device manufacturers.

Scale Opportunities A lean team structure presents a strong case for contract manufacturing fill finish or licensing agreements to speed commercialization while reducing internal overhead.

Regional Advantage Located in Danvers near Boston there is a strategic advantage to engage hospital systems clinicians and regional distributors to validate products and create early adoption opportunities.

Regulatory Readiness Established regulatory experience and a focused biomaterials portfolio can reassure strategic partners and enable smoother regulatory pathways for co developed products.